metricas
covid
Buscar en
Cirugía Española (English Edition)
Toda la web
Inicio Cirugía Española (English Edition) Efficacy of Fibrin-collagen Sealant for Reducing the Incidence of Biliary Fistul...
Información de la revista
Vol. 97. Núm. 2.
Páginas 120-121 (febrero 2019)
Vol. 97. Núm. 2.
Páginas 120-121 (febrero 2019)
Letter to the Editor
Acceso a texto completo
Efficacy of Fibrin-collagen Sealant for Reducing the Incidence of Biliary Fistulae After Laparoscopic Exploration of the Bile Duct
Eficacia del sellante de fibrina-colágeno para reducir la incidencia de fístulas biliares tras la exploración laparoscópica de la vía biliar
Visitas
1571
Pablo Parra-Membrivesa,b,
Autor para correspondencia
pabloparra@aecirujanos.es

Corresponding author.
, Darío Martínez-Baenab, José Manuel Lorente-Herceb, Ramón Martín-Balbuenab
a Departamento de Cirugía, Facultad de Medicina, Universidad de Sevilla, Sevilla, Spain
b Unidad de Cirugía Hepatobiliar y Pancreática, Servicio de Cirugía General y del Aparato Digestivo, Hospital Universitario de Valme, Sevilla, Spain
Este artículo ha recibido
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Texto completo
Dear Editor,

We appreciate the comments about our study by Dr. Martínez-Isla et al.1 We share his interest in the transcystic approach, which has indeed demonstrated a reduction in the incidence of biliary fistulae.2 Our transcystic exploration cases are not included in the article we published, since our objective was to try to establish the reduction in biliary leaks after choledochorraphy using sealants. However, we feel that transcystic exploration is more complex, often technically impossible, and does not guarantee complete exploration of the bile duct. There is a 10%–25% variation in the implantation of the cystic duct, running parallel to the bile duct or inserting into the left side of the common bile duct.3,4 This makes access difficult, so that complete dissection of the cystic duct can lead to injury to common bile duct vascularization. As a result, the risk/benefit balance does not clearly lean toward the transcystic approach.

Under these conditions, exploration of the bile duct proximal to the cystic implantation is not always possible, so the removal of stones in this area can be hindered. Furthermore, in our setting there is a significant amount of choledocholithiases that are much larger than the cystic duct, preventing extraction by this route. Fragmentation is difficult, as most hospitals do not have lasers. In addition, we do not share the indication of its use, as it increases the number of extraction maneuvers necessary and the risk of residual lithiasis. The size of the cystic duct or calculi and the number of stones and their location have been shown to be predictors of failed transcystic exploration.5 On occasion, we have used pneumatic dilatation of the cystic duct to facilitate the insertion of the choledochoscope and extraction of the calculus, but this maneuver can cause cystic ischemia, delayed necrosis and the appearance of biliary peritonitis. Lastly, excessive manipulation of 3-mm fiber optic choledochoscopes, given the weakness of their protective covering, often results in the loss of this seal, which requires more frequent repairs and must be added to the costs of the surgery.

We have not had any cases of pancreatitis due to transpapillary stents, as the authors of the comments to our study have mentioned. We believe that the fistula rate may be related to the fact that we strictly apply the ISGLS classification, which was not really created for this purpose,6 although it is all we have available to date.

In short, we share the enthusiasm for the transcystic pathway that we use, like most groups,7 when it comes to extracting solitary stones measuring less than one centimeter in patients with normally inserted cystic ducts. Nonetheless, we believe that, at least in our setting, use of the transcholedochal approach continues to be more frequent and completely necessary.

References
[1]
A. Martínez Isla, L. Navaratne, J. Quiñones Sampedro, D. MArtínez-Cecilia.
Efficacy of fibrin-collagen sealant for reducing the incidence of biliary fistulae after laparoscopic exploration of the bile duct.
Cir Esp, (2018),
pii:S0009-739X(18)30290-2 [Epub ahead of print]
[2]
Y. Zhou, W.Z. Zha, X.D. Wu, R.G. Fan, B. Zhang, Y.H. Xu, et al.
Three modalities on management of choledocholithiasis: a prospective cohort study.
Int J Surg, 44 (2017), pp. 269-273
PubMed PMID: 28668286
[3]
T. Hyodo, S. Kumano, F. Kushihata, M. Okada, M. Hirata, T. Tsuda, et al.
CT and MR cholangiography: advantages and pitfalls in perioperative evaluation of biliary tree.
Br J Radiol, 85 (2012), pp. 887-896
PubMed PMID: 22422383. Pubmed Central PMCID: 3474084
[4]
L.H. Blumgart, L.E. Hann.
Surgical and radiologic anatomy of the liver, biliary tract and pancreas.
Blumgart's surgery of the liver, biliary tract, and pancreas 1, 5th ed., pp. 31-57
[5]
M.H. Al-Temimi, S. Rangarajan, B. Chandrasekaran, E.G. Kim, C.N. Trujillo, A.F. Mousa, et al.
Predictors of failed transcystic laparoscopic common bile duct exploration: analysis of multicenter integrated health system database.
J Laparoendosc Adv Surg Tech A, 12 (2018 Sep),
PubMed PMID: 30207856
[6]
M. Koch, O.J. Garden, R. Padbury, N.N. Rahbari, R. Adam, L. Capussotti, Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery, et al.
Surgery, 149 (2011), pp. 680-688
PubMed PMID: 21316725
[7]
L. Pang, Y. Zhang, Y. Wang, J. Kong.
Transcystic versus traditional laparoscopic common bile duct exploration: its advantages and a meta-analysis.
Surg Endosc, 32 (2018), pp. 4363-4376
PubMed PMID: 29943056

Please cite this article as: Parra-Membrives P, Martínez-Baena D, Lorente-Herce JM, Martín-Balbuena R. Eficacia del sellante de fibrina-colágeno para reducir la incidencia de fístulas biliares tras la exploración laparoscópica de la vía biliar. Cir Esp. 2019;97:120–121.

Copyright © 2018. AEC
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.cireng.2021.12.005
No mostrar más